Robert Scott McDowell Insider Trading $SNSS Viracta Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Scott McDowell.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Scott McDowell. Robert Scott McDowell is Vice President, Research in SUNESIS PHARMACEUTICALS INC ($SNSS) and Chief Scientific Officer in MyoKardia Inc ($MYOK) and See Remarks in MyoKardia Inc ($MYOK) and Senior VP, Drug Discovery in MyoKardia Inc ($MYOK).

Robert Scott McDowell in Viracta Therapeutics, Inc.

Trading Symbol: SNSS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Scott McDowell: Vice President, Research
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 14 2007
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert Scott McDowell in Viracta Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, MYOK, SNSS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 14 2007SNSSSUNESIS PHARMACEUT ...McDowell Robert ScottVice President, Res ...Option ExerciseA2.5960,000155,40060,000

Page:   1